Sign in / Join Now
ETFs & Funds
James Stocklasar Thomas Jr.
taunts day-traders. Be careful. MMs will have you for lunch.
Add a reply...
Latest StockTalks »
people get CTIC breaking news and analysis by email alert.
Get email alerts on CTIC »
CTI BioPharma Corp.
Get latest price
From other sites
CTI BioPharma Granted 180 Day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule
at TheStreet (Thu, 1:30AM)
CTI BioPharma Reports Mixed Pacritinib Study Data, Stock Up
at Zacks.com (Aug 30, 2016)
CTI BioPharma Meets One Of Two Endpoints In Phase 3 Trial
at Benzinga (Aug 29, 2016)
CTI BioPharma Announces Top-Line Results From PERSIST-2 Phase 3 Trial Of Pacritinib For High-Risk Patients With Advanced Myelofibrosis
at TheStreet (Aug 29, 2016)
Surging Earnings Estimates Signal Good News for CTI BioPharma (CTIC)
at Zacks.com (Jun 10, 2016)